Amphastar P - Asset Resilience Ratio

Latest as of June 2026: 3.81%

Amphastar P (AMPH) has an Asset Resilience Ratio of 3.81% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AMPH working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$66.51 Million

Cash + Short-term Investments

Total Assets

$1.74 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Amphastar P's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see AMPH current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Amphastar P's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Amphastar P long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$66.51 Million	3.81%
Total Liquid Assets	$66.51 Million	3.81%

Asset Resilience Insights

Limited Liquidity: Amphastar P maintains only 3.81% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Amphastar P Industry Peers by Asset Resilience Ratio

Compare Amphastar P's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Amphastar P (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Amphastar P.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.91%	$112.64 Million	$1.63 Billion	+2.47pp
2024-12-31	4.44%	$70.04 Million	$1.58 Billion	-3.00pp
2023-12-31	7.44%	$112.51 Million	$1.51 Billion	+4.79pp
2022-12-31	2.65%	$19.66 Million	$741.99 Million	+1.11pp
2021-12-31	1.54%	$10.32 Million	$671.53 Million	-0.52pp
2020-12-31	2.06%	$12.98 Million	$631.24 Million	-0.32pp
2019-12-31	2.38%	$13.96 Million	$586.97 Million	+1.83pp
2018-12-31	0.55%	$2.83 Million	$513.56 Million	-0.03pp
2017-12-31	0.58%	$2.63 Million	$454.67 Million	+0.46pp
2016-12-31	0.12%	$527.00K	$427.74 Million	-0.21pp
2015-12-31	0.33%	$1.28 Million	$390.14 Million	-0.05pp
2014-12-31	0.38%	$1.50 Million	$389.37 Million	-0.01pp
2013-12-31	0.39%	$1.32 Million	$338.75 Million	-0.20pp
2012-12-31	0.59%	$1.89 Million	$317.48 Million	--

pp = percentage points

About Amphastar P

NASDAQ:AMPH USA Drug Manufacturers - Specialty & Generic

Market Cap

$1.01 Billion

Market Cap Rank

#9026 Global

#2555 in USA

Share Price

$23.82

Change (1 day)

-0.54%

52-Week Range

$16.87 - $29.40

All Time High

$65.00